ClinConnect ClinConnect Logo
Search / Trial NCT06462521

Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection

Launched by INDIANA UNIVERSITY · Jun 12, 2024

Trial Information

Current as of June 26, 2025

Enrolling by invitation

Keywords

Polyp Resection Cold Snare Cold Endoscopic Mucosal Resection (Cold Emr) Cold Snare Piecemeal Resection (Cspr) Colonoscopy

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. ≥ 18 years of age
  • 2. Presenting for a screening, surveillance, diagnostic, or therapeutic colonoscopy
  • 3. Found to have:
  • a sessile serrated lesion or hyperplastic polyp ≥ 10 mm during procedure (Serrated Cohort) or
  • a 10-19 mm conventional adenoma during procedure (Adenoma Cohort)
  • 4. Ability to provide informed consent
  • Exclusion Criteria:
  • 1. Pedunculated or semi-pedunculated polyps (as defined by Paris Classification type Ip or Isp)
  • 2. Polyps confirmed to be anything other than:
  • sessile serrated lesion or hyperplastic polyp on histologic diagnosis (Serrated Cohort) or
  • conventional adenoma on histologic diagnosis (Adenoma Cohort)
  • 3. Patients with Ulcerative Colitis or Crohn's disease
  • 4. Polyps with features suggestive of submucosal invasion
  • 5. Polyps that are not able to be removed endoscopically due to location (e.g. extending into appendiceal orifice or diverticulum)
  • 6. Patients with a known or suspected diagnosis of any of the following polyposis syndromes with known genetic mutations:
  • Familial Adenomatous Polyposis Syndrome
  • MUTYH associated Polyposis Syndrome
  • Juvenile Polyposis Syndrome
  • Cowden's Syndrome
  • Peutz-Jeghers Syndrome
  • 7. Subjects whose colonoscopy procedure is not able to be completed due to bowel prep precluding polyp identification.

About Indiana University

Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.

Locations

Indianapolis, Indiana, United States

Patients applied

0 patients applied

Trial Officials

John J Guardiola, MD

Principal Investigator

Indiana University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported